Effect of continuing anticoagulants and antiplatelet drugs on perioperative total blood loss in total hip replacement: a prospective observational study

Effect of continuing anticoagulants and antiplatelet drugs on perioperative total blood loss in total hip replacement: a prospective observational study - Effect of continuing anticoagulants and antiplatelet drugs on perioperative total blood loss in total hip replacement: a prospective observational study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000038322

Enrollment

500

Registered

2019-10-18

Start date

2019-10-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of the hip, rheumatoid arthritis, avascular necrosis of the femoral head

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing total hip arthroplasty

Exclusion criteria

Exclusion criteria: Patients scheduled for revision total hip arthroplasty. Patients scheduled for total hip arthroplasty with shortening subtrochanteric osteotomy.

Design outcomes

Primary

Measure	Time frame
The volume of perioperative blood loss measured using the calculated blood volume and change in hemoglobin from preoperative to postoperative day 4.	—

Secondary

Measure	Time frame
Complication	—

Countries

Japan

Contacts

Public Contactkenji Kurosaka

Hokusuikai Kinen Hospital Orthopaedic surgery

kenjikurosaka@yahoo.co.jp029-303-3003

Outcome results